Regression and stabilization of atherogenic plaques

Jairo Aldana-Bitar1, Deepak L Bhatt2, Matthew J Budoff1

  • 1The Lundquist Institute at Harbor-UCLA Medical Center, Division of Cardiology, Los Angeles, CA, USA.

Insights

Understanding atherosclerotic plaque regression and stabilization is key for cardiovascular disease treatment. This review covers current knowledge, imaging methods, and interventions for managing plaque progression and instability.

Area of Science:

  • Cardiovascular Medicine
  • Medical Imaging
  • Pharmacology

Background:

  • Atherosclerotic plaque assessment is vital in cardiovascular disease management.
  • Plaque progression and instability pose significant risks if untreated.
  • Plaque regression and stabilization are primary goals of cardiovascular interventions.

Purpose of the Study:

  • To review the current understanding of atherosclerotic plaque regression and stabilization.
  • To discuss contemporary imaging and measurement techniques for plaque assessment.
  • To examine evidence for pharmacological and other interventions targeting plaque modification.

Main Methods:

  • Literature review of current research on plaque regression and stabilization.
  • Analysis of various imaging modalities used for plaque characterization.
  • Evaluation of clinical trial data on interventions for plaque modification.

Main Results:

  • Current understanding of plaque regression and stabilization mechanisms is evolving.
  • Advanced imaging techniques offer improved plaque assessment capabilities.
  • Evidence supports various pharmacological and interventional strategies for plaque stabilization.

Conclusions:

  • Effective plaque regression and stabilization strategies are crucial for improving cardiovascular outcomes.
  • Continued research in imaging and therapeutic interventions is necessary.
  • Personalized treatment approaches may enhance plaque management in cardiovascular medicine.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Inflammation01:38

Inflammation

Overview
53.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
13
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
699